- Home
- INTR vs SLNO Comparison
INTR vs SLNO Comparison
Compare INTR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTR
- SLNO
- Stock Information
- Founded
- INTR 1994
- SLNO 1999
- Country
- INTR Brazil
- SLNO United States
- Employees
- INTR N/A
- SLNO N/A
- Industry
- INTR
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INTR
- SLNO Health Care
- Exchange
- INTR Nasdaq
- SLNO Nasdaq
- Market Cap
- INTR 2.1B
- SLNO 1.9B
- IPO Year
- INTR N/A
- SLNO 2014
- Fundamental
- Price
- INTR $4.75
- SLNO $49.17
- Analyst Decision
- INTR Strong Buy
- SLNO Strong Buy
- Analyst Count
- INTR 4
- SLNO 6
- Target Price
- INTR $7.13
- SLNO $74.83
- AVG Volume (30 Days)
- INTR 1.8M
- SLNO 567.7K
- Earning Date
- INTR 02-06-2025
- SLNO 03-05-2025
- Dividend Yield
- INTR 2.54%
- SLNO N/A
- EPS Growth
- INTR 295.93
- SLNO N/A
- EPS
- INTR 0.33
- SLNO N/A
- Revenue
- INTR $767,729,562.00
- SLNO N/A
- Revenue This Year
- INTR N/A
- SLNO N/A
- Revenue Next Year
- INTR $24.01
- SLNO N/A
- P/E Ratio
- INTR $14.17
- SLNO N/A
- Revenue Growth
- INTR 38.44
- SLNO N/A
- 52 Week Low
- INTR $3.88
- SLNO $36.61
- 52 Week High
- INTR $7.84
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- INTR 57.46
- SLNO 56.57
- Support Level
- INTR $4.20
- SLNO $45.44
- Resistance Level
- INTR $4.84
- SLNO $49.03
- Average True Range (ATR)
- INTR 0.13
- SLNO 2.36
- MACD
- INTR 0.11
- SLNO 0.66
- Stochastic Oscillator
- INTR 89.29
- SLNO 98.40
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.